Maple Finance (SYRUP) is up by 2% at press time on Friday, rising above the 200-day Exponential Moving Average (EMA) at $0.3853. The lending protocol’s revenue hit a record high of $2.49 million in December, underscoring accelerated adoption and user demand.
SYRUP is up over 2% so far on Friday, extending gains above the 200-day EMA.Maple Finance hit a record-high revenue of $2.49 million in December, while AUM remains above $4.28 billion.The technical outlook is still bullish as trend momentum stabilizes.
Maple Finance is up by 2% at press time on Friday, rising above the 200-day Exponential Moving Average at $0.3853. The lending protocol’s revenue hit a record high of $2.49 million in December, underscoring accelerated adoption and user demand. The technical outlook for SYRUP points to further gains as the momentum indicators signal a stable upward trend.Maple Finance revenue surges as ecosystem expandsMaple Finance's revenue, mainly collected from lending fees and yield optimization, reached a record high of $2.49 million in December. A steady inflow of revenue in 2025 exceeded $15 million in total, indicating a surge in market adoption, particularly from financial institutions.Maple Finance monthly revenue. Source: DuneMeanwhile, the protocol’s Asset Under Management exceeds $4.28 billion, with outstanding loan balances of $1.18 billion. This expansion in AUM and revenue highlights the growth of Maple Finance’s ecosystem, which could translate to higher demand for its native token, SYRUP.Maple Finance protocol data. Source: DuneSYRUP prepares for extended rallySYRUP extends gains above the 200-day EMA at $0.3853 by 2% at press time on Friday, amounting to nearly 6% so far this week. This marks the second week of gains following last week's 14% recovery. The lending protocol’s token struggles to continue its recovery above the $0.4000 round figure, which recently capped Tuesday’s surge. Still, a decisive close above this level could target the R2 Pivot Point at $0.4297, followed by the R3 Pivot Point at $0.4991.The technical indicators on the daily chart flash mixed signals amid the ongoing rally. The Relative Strength Index is at 67, rising toward the overbought zone, suggesting heightened buying pressure. At the same time, the Average Directional Index indicator turns flat around 28, indicating that the trend is stabilizing. SYRUP/USDT daily price chart.Looking down, if SYRUP dips below the R1 Pivot Point at $0.3760, which is roughly close to the 200-day EMA at $0.3853, the 100-day and 50-day EMAs at $0.3542 and $0.3388 could serve as support levels.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Learn self-sufficient living at Lake Metroparks Homesteading WeekendThe two-day event offers sessions on vegetable gardening, raising chickens, maple sugaring and equipment maintenance for all experience levels.
Read more »
NANT Global Finance Unveils Fully Integrated Blockchain Platform for Tokenized Securities and Real-Time SettlementFollowing the strategic acquisition of Horizon Globex and several U.S. broker-dealers, NANT Global Finance is bridging the gap between traditional Wall Street and digital assets, backed by Dr. Patrick Soon-Shiong and the Los Angeles Times Media Group.
Read more »
Maple Leafs vs Flyers Prediction, Picks & Same-Game Parlay for Tonight’s NHL GameBet on Auston Matthews' goal prop as we dish on our Maple Leafs vs. Flyers picks, odds & expert predictions for Thursday, January 8.
Read more »
Noah Juulsen is the next man up for the banged-up Flyers; Scott Laughton returns ‘home’ to PhillyWith Jamie Drysdale injured, Juulsen will get back into the lineup on defense as the Flyers host the Toronto Maple Leafs and old friend Laughton.
Read more »
Scott Laughton scores in his return to Philly as the Maple Leafs beat the Flyers, 2-1, in overtimeLaughton tied the game in the third period and his teammate Easton Cowan scored the game-winner in the extra frame. Travis Konecny opened the scoring in the second period.
Read more »
Senators slam 'trolls and sick people' as rumors spread about Linus Ullmark's absenceUllmark has not played since Dec. 27 against the Maple Leafs.
Read more »